Vlasic Labs CBD Products Qualify for CMS CBD Pilot Program, Marking Historic Step for Cannabinoid Therapies

BLOOMFIELD HILLS, Mich. , March 31, 2026 /PRNewswire/ -- Vlasic Labs today announced that its CBD product line meets the current qualifications outlined in the Centers for Medicare & Medicaid Services (CMS) pilot program, a first-of-its-kind initiative allowing participating healthcare...